Last reviewed · How we verify
NCT07352982
Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea
NA trial testing Transcutaneous tibial nerve stimulation (TTNS) in Transcutaneous Tibial Nerve Stimulation in 32 participants. Currently enrolling.
1 July 2026
Quick facts
| Lead sponsor | Kafrelsheikh University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 19 January 2026 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 July 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Transcutaneous tibial nerve stimulation (TTNS)
- Traditional treatment (Nonsteroidal anti-inflammatory drugs) — full drug profile →
Conditions studied
- Transcutaneous Tibial Nerve Stimulation — all drugs for Transcutaneous Tibial Nerve Stimulation →
- Women — all drugs for Women →
- Primary Dysmenorrhea — all drugs for Primary Dysmenorrhea →
Sponsor
Kafrelsheikh University
Who can join
Adults 20 to 25, female only, with Transcutaneous Tibial Nerve Stimulation or Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the effects of transcutaneous tibial nerve stimulation (TTNS) on women with primary dysmenorrhea (PD).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07352982
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcutaneous tibial nerve stimulation (TTNS)
Trials testing the same drug.
- NCT06385769 — Transcutaneous Tibial Nerve Stimulation in Patients With Neurogenic Overactive Bladder After Stroke · NA · not yet recruiting
- NCT06349694 — Comparison of the Efficacy of Transcutaneos Nerve Stimulations in Women With Idiopathic Overactive Bladder · NA · unknown
- NCT05668715 — Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder · NA · unknown
Other Kafrelsheikh University trials
Trials by the same sponsor.
- NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
- NCT07433920 — L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation · NA · recruiting
- NCT07368348 — Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cere · NA · recruiting
- NCT07348094 — Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin · NA · recruiting
- NCT07359144 — Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07352982 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kafrelsheikh University
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07352982.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing